NIHR Global Health Research Unit (GHRU) on Diabetes and Cardiovascular Disease in South Asians is a research collaboration between Bangladesh, India, Pakistan, Sri Lanka and the United Kingdom.

Our aim is to reduce the burden of Type-2 Diabetes and Cardiovascular Disease in South Asia.

To achieve this aim, we bring together expertise in the fields of public health, health promotion, health policy, nutrition, community interventions, epigenomics and genomics and actively engage key stakeholders, decision makers and policy makers.
We aim to achieve impact by:

Strengthening disease surveillance mechanisms for T2D and CVD to assess needs, priorities and performance

Prioritise interventions for prevention, early detection and treatment of T2D and CVD, considering efficacy, sustainability and scalability

Supporting capacity building and investing in high-quality training of both health care workers and translational researchers

Developing frameworks and engaging key stakeholders, decision makers and policy makers for an effective dissemination and implementation of our research